what are the benefits of tirzepatide besides weight loss JLA :: Journal Lipid and Atherosclerosis The Cardiovascular Effect of Tirzepatide:

Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company's new orforglipron pill can offer up to an average of 27.3 pounds of weight loss, according to results from the first of two of its Phase 3 trials that included more than 3,100 overweight or obese adults

Introduction The past years have witnessed major advances in our understanding of the underlying mechanisms involved in the bodily response to stress (Chrousos and Zoumakis, 2015

While Mounjaro is not available, Zepbound is offered through the Body Program

Citations Rosenstock J, Wysham C, Fras JP, et al

first FDA-approved oral therapy for pheochromocytoma or paraganglioma (PPGL) New indication: for treatment of adult and pediatric patients 12 years of age with locally advanced, unresectable, or metastatic PPGL Administered orally once daily with or without food